Spero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 506 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 176-200 of 506 matching filings.

Per page
25
Current page
8
4

FORM 4 SUBMISSION

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Sep 2022
Reporting date
12 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
14 Sep 2022
Reporting date
12 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Aug 2022
Reporting date
29 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38266

DEFA14A

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38266

DEF 14A

Filing date
05 Aug 2022
Reporting date
15 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

SC 13G filing

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Apr 2022
Reporting date
26 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Mar 2022
Reporting date
30 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .